The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Polyzos, Stergios  [Clear All Filters]
Journal Article
Tsourdi, E., Makras P., Rachner T. D., Polyzos S., Rauner M., Mandanas S., et al. (2019).  Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment.. Bone. 120, 44-49.
Deretzi, G., Kountouras J., Koutlas E., Zavos C., Polyzos S., Rudolf J., et al. (2010).  Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.. Mult Scler. 16(9), 1091-101.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Polyzos S., Vardaka E., et al. (2011).  Helicobacter pylori may play an important role in both axonal type Guillain-Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy.. Clin Neurol Neurosurg. 113(6), 520.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Polyzos S., Katsinelos P., et al. (2011).  Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction.. J Neuroimmunol. 233(1-2), 254-6; author reply 257-8.
Kountouras, J., Zavos C., Papadopoulos A., Deretzi G., & Polyzos S. (2011).  Irritable bowel syndrome associated with mitral valve prolapse and autonomic and haemostatic abnormalities in children, adolescents and adults with migraine.. Acta Neurol Scand. 123(5), 366-7.
Muzurović, E., Polyzos S., Mikhailidis D., Borozan S., Novosel D., Cmiljanić O., et al. (2022).  Non-alcoholic fatty liver disease in children.. Curr Vasc Pharmacol.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.